Eksempel: Heart Attack

Søg i kliniske forsøg efter: Aspirin, dipyridamole drug combination

I alt 27 resultater

NCT02273531

Afsluttet

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Betingelser: Healthy
NCT02273479

Afsluttet

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers

Betingelser: Healthy
NCT02273492

Afsluttet

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

Betingelser: Healthy
NCT02269228

Afsluttet

Tolerability of Asasantin in Healthy Female and Male Subjects

Betingelser: Healthy
NCT02273518

Afsluttet

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Betingelser: Healthy
NCT00311402

Afsluttet

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Betingelser: Cerebrovascular Accident
NCT02273557

Afsluttet

Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects

Betingelser: Healthy
NCT00274586

Afsluttet

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

Betingelser: Cerebrovascular Accident
NCT02278302

Afsluttet

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Betingelser: Healthy
NCT02273544

Afsluttet

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects

Betingelser: Healthy
NCT01303445

Afsluttet

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

Betingelser: Healthy
NCT00562588

Afsluttet

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Betingelser: Cerebrovascular Accident
NCT00067119

Afsluttet

Aggrenox Prevention of Access Stenosis

Betingelser: Kidney Failure
NCT02273505

Afsluttet

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Betingelser: Healthy
NCT04410328

Rekruttering

Aggrenox To Treat Acute Covid-19

Betingelser: Covid19
NCT02251184

Afsluttet

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

Betingelser: Healthy
NCT00153062

Afsluttet

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Betingelser: Stroke
NCT02268773

Afsluttet

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

Betingelser: Healthy
NCT02226926

Afsluttet

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

Betingelser: Healthy
NCT01781611

Afsluttet

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)

Betingelser: Systemic Lupus Erythematosus
NCT00223717

Afsluttet

Treatment of Supine Hypertension in Autonomic Failure

Betingelser: Hypertension
NCT02630862

Afsluttet

Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization

Betingelser: Carotid Stenosis; Cardiovascular Disease; Atherosclerosis; Stroke
NCT00129038

Afsluttet

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Betingelser: Coronary Arteriosclerosis
NCT02262793

Afsluttet

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

Betingelser: Healthy
NCT00562289

Afsluttet

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence

Betingelser: Ischemic Stroke; Patent Foramen Ovale; Atrial Septal Aneurysm; Migraine